DiaMedica Therapeutics CEO Rick Pauls' 2019 pay jumps 105% to $1.5M
DiaMedica Therapeutics reports 2019 executive compensation
By ExecPay News
Published: April 20, 2020
DiaMedica Therapeutics reported fiscal year 2019 executive compensation information on April 20, 2020.
In 2019, three executives at DiaMedica Therapeutics received on average a compensation package of $986K, a 64% increase compared to previous year.
Average pay of disclosed executives at DiaMedica Therapeutics
Rick Pauls, Chief Executive Officer, received $1.5M in total, which increased by 105% compared to 2018. 59% of Pauls' compensation, or $891K, was in option awards. Pauls also received $178K in non-equity incentive plan, $420K in salary, as well as $15K in other compensation.
Harry Alcorn, Jr., Chief Medical Officer, received a compensation package of $778K. 54% of the compensation package, or $422K, was in option awards.
Scott Kellen, Chief Financial Officer, earned $678K in 2019, a 5% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 20, 2020.